Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “dendritic”

49 pharma patents match "dendritic" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 49
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 49 pharmaceutical patents matching "dendritic" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

49 results for “dendritic” · 30,257 patents in full index Clear search

  1. US 12410225

    Modulation of dendritic cell lineages

    Orionis Biosciences, Inc · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted

  2. US 12157901

    Dendritic cell generator

    Northwestern University · Granted Dec 3, 2024 · Expires Nov 28, 2044

    granted

  3. US 12031008

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted

  4. US 11976299

    Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2024 · Expires May 2, 2044

    granted

  5. US 11760858

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  6. US 11680244

    Method for generating human dendritic cells for immunotherapy

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  7. US 11638753

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    PDS Biotechnology Corporation · Granted May 2, 2023 · Expires Apr 27, 2043

    granted

  8. US 11634507

    Dendritic gold nanoparticles and methods of synthesis

    The Board of Regents of the University of Oklahoma · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  9. US 11612652

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    PDS Biotechnology Corporation · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  10. US 11598015

    Fabrication of dendritic structures and tags

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

  11. US 11566224

    Dendritic cell generator

    Northwestern University · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  12. US 11124768

    Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response

    Northwest Biotherapeutics, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  13. US 11027001

    Therapeutic cancer vaccines derived from a novel dendritic cell line

    DCPRIME B.V. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  14. US 10982068

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  15. US 10946080

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  16. US 10765727

    Compositions and methods for producing dendritic cells

    PrimeVax Immuno-Oncology · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

  17. US 10731131

    Dendritic cell generator

    Northwestern University · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  18. US 10442911

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  19. US 10357553

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  20. US 10253294

    Galactose oxidase treatment of dendritic cells to improve their immunogenicity

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  21. US 10183080

    Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  22. US 10159727

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  23. US 10064923

    Therapeutic cancer vaccines derived from a novel dendritic cell line

    DCPRIME B.V. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  24. US 10036751

    Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment

    China Medical University Hospital · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.